13F Holdings
中文EN

SKVI SKINVISIBLE, INC.

Pharmaceutical Preparations · OTC · SEC CIK 1085277 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY5.8%
TTM net income YoY-111.2%
TTM EPS YoY—
Revenue 3-yr CAGR1.9%
Net income 3-yr CAGR—

Margins

Gross margin100.0%
Operating margin-2,193.7%
Net margin-4,898.2%
FCF margin—
EBITDA margin-2,097.8%

Returns

ROE—
ROA-829.6%
ROIC (approx.)—
Asset turnover0.17x

Leverage & solvency

Liabilities / assets9,592.8%
Debt / equity—
Current ratio0.01x
Interest coverage-0.81x

Cash quality & payout

Operating cash flow / net income0.08x
Accruals ratio-759.9%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$20,000$20,000$20,000$279,296$663,426
Cost of revenue———$4,808$3,300
Gross profit$20,000$20,000$20,000$274,488$660,126
SG&A expense$496,076$589,151$491,604$494,182$454,107
Operating income-$496,315-$589,589-$490,375-$238,432$188,080
Interest expense$572,249$669,438$1.89M$1.16M$1.21M
Net income-$1.06M-$565,654-$2.38M-$1.22M-$1.07M
EBITDA-$476,076-$569,151-$471,604-$219,694$206,019
EPS (diluted)—-0.11-0.52-0.27-0.24
Weighted avg. shares (diluted)—5.06M4.54M4.54M4.54M
Balance sheet
Cash & equivalents$2,620$10,336$888$81,378$66,037
Receivables$5,000$5,000$5,000$5,000—
Current assets$27,531$42,028$35,460$109,946$74,244
Intangibles$100,036$116,189$127,409$136,847$153,055
Total assets$127,567$158,217$162,869$246,793$227,299
Current liabilities$5.02M$3.66M$3.51M$3.64M$3.06M
Total liabilities$10.39M$9.38M$9.19M$6.89M$5.64M
Shareholders' equity-$10.26M-$9.22M-$9.02M-$6.64M-$5.42M
Shares outstanding5.40M5.32M4.54M4.54M4.54M
Cash flow statement
Operating cash flow-$38,410-$69,834-$77,157$45,170$374,605
Capital expenditure$4,086$9,218———
Free cash flow-$42,496-$79,052———
Investing cash flow-$4,086-$9,218-$9,333-$2,530-$20,864
Financing cash flow$34,780$88,500$6,000-$27,299-$323,600
Depreciation & amortization$20,239$20,438$18,771$18,738$17,939

Free plan shows the latest 5 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.